Core Insights - Faraday Future Intelligent Electric Inc. (FF) has signed a securities purchase agreement with Qualigen Therapeutics, Inc. (QLGN) to invest in QLGN's common and preferred stock through a private investment in public equity (PIPE) totaling approximately $41 million [1] Investment Details - The PIPE investment is led by Faraday Future and its co-CEO Jia Yueting, with participation from other investors including SIGN Foundation, which is supported by Binance Labs, Sequoia Capital (U.S., India, China), IDG, and Circle [1] - FF's global president Jerry Wang also participated in this investment round [1] Strategic Collaboration - The partnership aims to fully cooperate in developing cryptocurrency and Web3 business initiatives [1]
FF宣布4100万美元战略投资纳斯达克上市公司QLGN